Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

AIM: Direct‐acting oral anticoagulants (DOACs) have become available for the prevention of stroke in patients with atrial fibrillation (AF). Conflicting results have been published on the risk of acute myocardial infarction (AMI) with the use of DOACs in comparison with vitamin K antagonists (VKAs)....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Br J Clin Pharmacol
Hauptverfasser: Stolk, Leo M., de Vries, Frank, Ebbelaar, Chiel, de Boer, Anthonius, Schalekamp, Tom, Souverein, Patrick, ten Cate‐Hoek, Arina, Burden, Andrea M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2017
Schlagworte:
Pharmacoepidemiology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495191/
https://ncbi.nlm.nih.gov/pubmed/28326589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13264
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge